Organogenesis Holdings (ORGO) Gross Profit (2017 - 2026)

Organogenesis Holdings' Gross Profit history runs 10 years deep, the most recent figure standing at $11.5 million for Q1 2026.

• On a quarterly basis, Gross Profit fell 81.81% year-over-year to $11.5 million in Q1 2026; TTM through Mar 2026 was $375.1 million, a 7.8% increase from a year earlier, with the FY2025 full-year figure at $426.6 million, up 16.47% from the prior year.
• Gross Profit slipped to $11.5 million in Q1 2026 per ORGO's latest filing, from $175.7 million in the prior quarter.
• Across five years, Gross Profit topped out at $175.7 million in Q4 2025 and bottomed at $11.5 million in Q1 2026.
• The 5-year median for Gross Profit is $88.4 million (2024), against an average of $86.9 million.
• Across the five-year window, Gross Profit jumped 83.77% in 2025 and slumped 81.81% in 2026, its largest moves.
• Year by year, Gross Profit stood at $88.4 million in 2022, then dropped by 18.69% to $71.9 million in 2023, then soared by 33.0% to $95.6 million in 2024, then soared by 83.77% to $175.7 million in 2025, then sank by 93.48% to $11.5 million in 2026.
• Per Business Quant, the three latest ORGO Gross Profit figures stand at $11.5 million (Q1 2026), $175.7 million (Q4 2025), and $114.6 million (Q3 2025).